Sort by
Search results
FVIII Inhibitor Plasma (2) Moderate (11-50 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
FVII Inhibitor Plasma (2) Moderate (11-50 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
HEMOCLOT Quanti. V-L
Quantitative measurement of Factor V Leiden, resistant to the action of activated protein C (APC resistance), for diagnosing patients carrying the R506Q FV mutation (Factor V Leiden), or any FV mutant resistant to APC.
CEPHEN APTT LS 1 (Lupus Sensitive)
Measurement of the plasma recalcification time, in presence of the standardized aPTT (activated partial thromboplastin time) reagent (cephalin and activator), on human citrated plasma, to explore the activity of the intrinsic pathway coagulation factors (II, V, VIII, IX, X, XI, XII) and “anticoagulant” activities.
HEMOCLOT DTI 2.5 (Direct Thrombin Inhibitors)
Quantitative measurement of dabigatran, and anti-thrombin activities in plasma.
HEMOCLOT DTI 1 (Direct Thrombin Inhibitors)
Quantitative measurement of dabigatran, and anti-thrombin activities in plasma.
BIOPHEN Protein C (LRT, Liquid Reagent Technology)
Diagnosis of congenital or acquired protein C deficiencies. Protein C concentrates.
BIOPHEN Protein C 5
Diagnosis of congenital or acquired protein C deficiencies. Protein C concentrates.
Factor XI EIA
Supplied with full step-by-step instructions for performing sandwich ELISAs. For research use only.
Factor VII, activated (VIIa), Human, Des-Gla
Factor VII, activated (VIIa), human, purified, Des-Gla (gla domainless)